This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Novartis Ag, Mabwell (Shanghai) Bioscience Co., Ltd.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Lichun Wang: Innovator in Polyomavirus Research
Introduction
Lichun Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of virology, particularly in the development of treatments for polyomavirus infections. With a total of seven patents to his name, Wang's work is recognized for its potential impact on public health.
Latest Patents
Among his latest patents, Wang has developed polyomavirus neutralizing antibodies. These inventions relate to anti-VP1 antibodies and antibody fragments, which are crucial for the prevention and treatment of polyomavirus infections and associated diseases. His innovative approach aims to provide effective therapeutic options for those affected by these viral infections.
Career Highlights
Wang is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His dedication to advancing medical science is evident in his extensive patent portfolio.
Collaborations
Wang has worked alongside notable colleagues such as Johanna Abend and Zorica Dragic. These collaborations have fostered a dynamic research environment, enabling the exchange of ideas and expertise that enhance the quality of their work.
Conclusion
Lichun Wang's contributions to the field of polyomavirus research exemplify the importance of innovation in medicine. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
